144 related articles for article (PubMed ID: 10933056)
1. BRCA1 partially reverses the transforming activity of the ras oncogene.
Kumar A; Knott C; Kuus-Reichel K; Saedi MS
Neoplasia; 1999 Nov; 1(5):417-23. PubMed ID: 10933056
[TBL] [Abstract][Full Text] [Related]
2. R-Ras promotes tumor growth of cervical epithelial cells.
Rincón-Arano H; Rosales R; Mora N; Rodriguez-Castañeda A; Rosales C
Cancer; 2003 Feb; 97(3):575-85. PubMed ID: 12548599
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
4. Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells.
Ciardiello F; Gottardis M; Basolo F; Pepe S; Normanno N; Dickson RB; Bianco AR; Salomon DS
Mol Carcinog; 1992; 6(1):43-52. PubMed ID: 1354442
[TBL] [Abstract][Full Text] [Related]
5. Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells.
Huber BE; Cordingley MG
Oncogene; 1988 Sep; 3(3):245-56. PubMed ID: 3060790
[TBL] [Abstract][Full Text] [Related]
6. Detection and cloning of potent transforming gene(s) from chewing tobacco-related human oral carcinomas.
Saranath D; Bhoite LT; Deo MG; Tandle AT; D'Costa J; Kolhapure RN; Govardhan MK; Banerjee K
Eur J Cancer B Oral Oncol; 1994 Jul; 30B(4):268-77. PubMed ID: 7950842
[TBL] [Abstract][Full Text] [Related]
7. Cooperation of p53 loss of function and v-Ha-ras in transformation of mouse keratinocyte cell lines.
Azzoli CG; Sagar M; Wu A; Lowry D; Hennings H; Morgan DL; Weinberg WC
Mol Carcinog; 1998 Jan; 21(1):50-61. PubMed ID: 9473771
[TBL] [Abstract][Full Text] [Related]
8. Correlation of growth capacity of cells in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites.
Fidler IJ; Li LM; Ananthaswamy HN; Esumi N; Radinsky R; Price JE
Anticancer Res; 1991; 11(1):17-24. PubMed ID: 2018350
[TBL] [Abstract][Full Text] [Related]
9. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
10. [The characteristics of the transformed phenotype and the expression of indicator plasmids in the cells of rat embryonic fibroblasts immortalized by oncogene E1Aad5 and transformed by oncogenes E1Aad5+c-Ha-ras].
Pospelova TV; Kisliakova TV; Medvedev AV; Svetlikova SB; Pospelov VA
Tsitologiia; 1990; 32(2):148-55. PubMed ID: 2142348
[TBL] [Abstract][Full Text] [Related]
11. A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.
Chang MY; Won SJ; Liu HS
J Cancer Res Clin Oncol; 1997; 123(2):91-9. PubMed ID: 9030247
[TBL] [Abstract][Full Text] [Related]
12. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
Wang B; Soule HD; Miller FR
Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
[TBL] [Abstract][Full Text] [Related]
13. Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.
Longstreet M; Miller B; Howe PH
Oncogene; 1992 Aug; 7(8):1549-56. PubMed ID: 1630817
[TBL] [Abstract][Full Text] [Related]
14. Oligonucleotide treatment of ras-induced tumors in nude mice.
Wickstrom E
Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
[TBL] [Abstract][Full Text] [Related]
15. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
16. Correlation between Ha-ras gene amplification and spontaneous metastasis in NIH 3T3 cells transfected with genomic DNA from human skin cancers.
Ananthaswamy HN; Price JE; Tainsky MA; Goldberg LH; Bales ES
Clin Exp Metastasis; 1989; 7(3):301-13. PubMed ID: 2647332
[TBL] [Abstract][Full Text] [Related]
17. Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene.
Schütte J; Minna JD; Birrer MJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2257-61. PubMed ID: 2648396
[TBL] [Abstract][Full Text] [Related]
18. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
19. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
20. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
